Search
for

    Sort by

    Research 391–420 of 507

    1. Evaluación de la eficacia y seguridad del tratamiento tópico y del tratamiento oral en la alopecia androgenética y hormonal Anales Médicos de la Asociación Médica del Centro Médico ABC · 2014
    2. In Search of Predictive Models for Inhibitors of 5-alpha Reductase 2 Based on the Integration of Bioactivity and Molecular Descriptors Data. IWBBIO · 2014
    3. Design, synthesis and structure-activity relationships studies on steroidal aromatase and 5α-reductase inhibitors as anti-tumors Estudo Geral (Universidade de Coimbra) · 2013
    4. Topic use of dutasteride for treatment of androgenic alopecia in male and female: A controlled pilot study Journal of clinical & experimental dermatology research · 2013
    5. Metabolic effects of 5α-reductase inhibition in humans Edinburgh Research Archive (University of Edinburgh) · 2013
    6. The preventive and therapeutic efficacy of finasteride and dutasteride in TRAMP mice The FASEB Journal · 2013
    7. 1378 CHARATERISTICS OF PATIENTS ON NON-DAILY AND DAILY DUTASTERIDE COMPARED TO PATIENTS CYTOREDUCTION NAIVE The Journal of Urology · 2013
    8. Association of 5-α reductase inhibitors and sexual dysfunction: A RADAR report Journal of The American Academy of Dermatology · 2013
    9. Major role for 5-alpha reductase inhibitors in the aging male Canadian Urological Association Journal · 2012
    10. Faculty Opinions recommendation of Promising therapies for treating and/or preventing androgenic alopecia. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2012
    11. Forum Pharmaceutical Medicine · 2012
    12. Re: Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men with Suppressed Testosterone Production: A Randomized Controlled Trial The Journal of Urology · 2012
    13. A method for simultaneous analysis of androgens, dutasteride and finasteride in human serum by liquid chromatography tandem mass spectrometry Society for Endocrinology BES 2012 · 2012
    14. Prostatakarzinom Der Urologe · 2011
    15. Efecto en el sangrado perioperatorio durante la resección transuretral de la próstata tras un mes de tratamiento con dutasteride Actas Urológicas Españolas · 2010
    16. Urological Oncology: Prostate Cancer 2010
    17. Editorial Comment Urology · 2010
    18. Finasteride had fewer sexual side effects compared to dutasteride in men with BPH Urology times · 2010
    19. New Drugs: Dutasteride Australian Prescriber · 2009
    20. Dutasteride: a guide to its use as monotherapy in benign prostatic hyperplasia Drugs & therapy perspectives · 2008
    21. PROSPECTIVE EVALUATION ON SEXUAL DYSFUNCTION PERSISTENCE, WORSENING OR IMPROVEMENT IN BPH PATIENTS AFTER FINASTERIDE OR DUTASTERIDE TREATMENT European Urology Supplements · 2008
    22. The Effect of 5α-Reductase Inhibition with Dutasteride and Finasteride on Semen Parameters and Serum Hormones in Healthy Men Yearbook of Endocrinology · 2008
    23. Slow progress in prostate cancer BJUI · 2007
    24. MP-09.08 Urology · 2006
    25. The role of dutasteride in the treatment of benign prostatic obstruction and related conditions Aging Health · 2006
    26. Medikamentöse Therapie des benignen Prostatasyndroms (BPS) Aktuelle Urologie · 2006
    27. Market Analysis of 5α-Reductase Inhibitor Zhongguo yaofang · 2006
    28. Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia. The Journal of Urology · 2005
    29. RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER 2005
    30. Successes and failures of evidence based urology 2005